BioCentury | Aug 7, 2020
Management Tracks

First chief diversity officer for Alexion; plus changes at WuXi, Dicerna, Valneva, MeiraGTx, Anika and more

...therapy company from Immunovant Inc. (NASDAQ:IMVT), where he held the same title. Joint therapeutics company Anika Therapeutics Inc....
...Activated Dendritic Cells” ). Robin Sawka, BioCentury Staff Alexion Pharmaceuticals Inc. WuXi Biologics Inc. Dicerna Pharmaceuticals Inc. Valneva SE MeiraGTx Holdings plc Anika Therapeutics Inc. Kira...
BioCentury | Jul 11, 2020
Management Tracks

Andrews joins Akcea as CMO; plus changes at Strongbridge, Abeona, Lyra, Kronos and more

...Inc. (NASDAQ:LYRA) hired Robert Richard as SVP of R&D. He was VP of R&D at Anika Therapeutics Inc....
BioCentury | Apr 30, 2020
Management Tracks

Desmond-Hellmann joins GV as adviser; plus Radius, Anika, AMAG, AiCure and more

...step down. He is succeeded by Kelly Martin, who was CEO of Elan Pharmaceuticals plc. Anika Therapeutics Inc....
...a venture partner. He was CTO of WuXi NextCode Genomics Inc. Robin Sawka, BioCentury Staff Radius Health Inc. Anika Therapeutics Inc. AMAG...
BioCentury | Mar 6, 2020
Management Tracks

Sharp steps down as Ultragenyx CFO; plus Axsome, ElevateBio, FasterCures, Satsuma, WindMIL and more

...Ts (see “ WindMIL: T cell Source is Key ”). Joint preservation and regeneration company Anika Therapeutics Inc....
...Staff Writer and Robin Sawka, BioCentury Staff Ultragenyx Pharmaceutical Inc. Axsome Therapeutics Inc. ElevateBio LLC Satsuma Pharmaceuticals Inc. WindMIL Therapeutics Inc. Anika Therapeutics Inc. Prothena...
BioCentury | Feb 1, 2020
Company News

Management tracks: Trio of female exec appointments; plus FDA, Cell and Gene Therapy Catapult, SutroVax, Lundquist Institute, RedShift, NeoImmuneTech and more

...director, pharmaceutical development at Albany Molecular Research Inc. before founding Falcon Pharma Tech in 2018. Anika Therapeutics Inc....
...Staff Writers Cell and Gene Therapy Catapult Los Angeles Biomedical Research Institute SutroVax Inc. NeoImmuneTech Inc. Insmed Inc. Moderna Inc. Bavarian Nordic A/S Anika Therapeutics Inc. Lundquist...
BioCentury | Jul 19, 2019
Finance

Earnings on deck

...7/24 Pre $2.33 $2.07 13% GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) 7/24 During (A) $0.62 $0.79 -22% Anika Therapeutics Inc....
BioCentury | Jul 8, 2019
Company News

Management tracks: Gritstone, ICMRA, Anika, Lyra

...chief executive of the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA). Regenerative medicines company Anika Therapeutics Inc....
...She was VP of technical operations at Adgero Biopharmaceuticals Holdings Inc. (Princeton, N.J.). Jonathan Block, Associate Editor Anika Therapeutics Inc. Gritstone...
BioCentury | Apr 26, 2019
Finance

Earnings on deck

...$0.06 17% Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA) 5/2 During (B) $0.58 $0.94 -38% Anika Therapeutics Inc....
BioCentury | Mar 29, 2019
Company News

Management tracks: Insmed, AACR, BlueRock

...Richard Hague as its new COO, effective April 8. Hague was chief commercial officer of Anika Therapeutics Inc....
BioCentury | Feb 16, 2019
Finance

Earnings on deck

...NYSE:BHC) 2/20 Pre $0.84 $0.98 -14% Genmab A/S (CSE:GEN; Pink:GMXAY) 2/20 Post DKK9.76 DKK12.65 -23% Anika Therapeutics Inc....
Items per page:
1 - 10 of 204
BioCentury | Aug 7, 2020
Management Tracks

First chief diversity officer for Alexion; plus changes at WuXi, Dicerna, Valneva, MeiraGTx, Anika and more

...therapy company from Immunovant Inc. (NASDAQ:IMVT), where he held the same title. Joint therapeutics company Anika Therapeutics Inc....
...Activated Dendritic Cells” ). Robin Sawka, BioCentury Staff Alexion Pharmaceuticals Inc. WuXi Biologics Inc. Dicerna Pharmaceuticals Inc. Valneva SE MeiraGTx Holdings plc Anika Therapeutics Inc. Kira...
BioCentury | Jul 11, 2020
Management Tracks

Andrews joins Akcea as CMO; plus changes at Strongbridge, Abeona, Lyra, Kronos and more

...Inc. (NASDAQ:LYRA) hired Robert Richard as SVP of R&D. He was VP of R&D at Anika Therapeutics Inc....
BioCentury | Apr 30, 2020
Management Tracks

Desmond-Hellmann joins GV as adviser; plus Radius, Anika, AMAG, AiCure and more

...step down. He is succeeded by Kelly Martin, who was CEO of Elan Pharmaceuticals plc. Anika Therapeutics Inc....
...a venture partner. He was CTO of WuXi NextCode Genomics Inc. Robin Sawka, BioCentury Staff Radius Health Inc. Anika Therapeutics Inc. AMAG...
BioCentury | Mar 6, 2020
Management Tracks

Sharp steps down as Ultragenyx CFO; plus Axsome, ElevateBio, FasterCures, Satsuma, WindMIL and more

...Ts (see “ WindMIL: T cell Source is Key ”). Joint preservation and regeneration company Anika Therapeutics Inc....
...Staff Writer and Robin Sawka, BioCentury Staff Ultragenyx Pharmaceutical Inc. Axsome Therapeutics Inc. ElevateBio LLC Satsuma Pharmaceuticals Inc. WindMIL Therapeutics Inc. Anika Therapeutics Inc. Prothena...
BioCentury | Feb 1, 2020
Company News

Management tracks: Trio of female exec appointments; plus FDA, Cell and Gene Therapy Catapult, SutroVax, Lundquist Institute, RedShift, NeoImmuneTech and more

...director, pharmaceutical development at Albany Molecular Research Inc. before founding Falcon Pharma Tech in 2018. Anika Therapeutics Inc....
...Staff Writers Cell and Gene Therapy Catapult Los Angeles Biomedical Research Institute SutroVax Inc. NeoImmuneTech Inc. Insmed Inc. Moderna Inc. Bavarian Nordic A/S Anika Therapeutics Inc. Lundquist...
BioCentury | Jul 19, 2019
Finance

Earnings on deck

...7/24 Pre $2.33 $2.07 13% GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) 7/24 During (A) $0.62 $0.79 -22% Anika Therapeutics Inc....
BioCentury | Jul 8, 2019
Company News

Management tracks: Gritstone, ICMRA, Anika, Lyra

...chief executive of the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA). Regenerative medicines company Anika Therapeutics Inc....
...She was VP of technical operations at Adgero Biopharmaceuticals Holdings Inc. (Princeton, N.J.). Jonathan Block, Associate Editor Anika Therapeutics Inc. Gritstone...
BioCentury | Apr 26, 2019
Finance

Earnings on deck

...$0.06 17% Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA) 5/2 During (B) $0.58 $0.94 -38% Anika Therapeutics Inc....
BioCentury | Mar 29, 2019
Company News

Management tracks: Insmed, AACR, BlueRock

...Richard Hague as its new COO, effective April 8. Hague was chief commercial officer of Anika Therapeutics Inc....
BioCentury | Feb 16, 2019
Finance

Earnings on deck

...NYSE:BHC) 2/20 Pre $0.84 $0.98 -14% Genmab A/S (CSE:GEN; Pink:GMXAY) 2/20 Post DKK9.76 DKK12.65 -23% Anika Therapeutics Inc....
Items per page:
1 - 10 of 204